Skip to content

Crenobalneotherapy in the Treatment of Chronic Venous Insufficiency

Crenobalneotherapy in the Treatment of Chronic Venous Insufficiency. A Randomized Clinical Trial.

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01956318
Enrollment
99
Registered
2013-10-08
Start date
2010-07-31
Completion date
2012-02-29
Last updated
2013-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Balneology

Keywords

Chronic venous insufficiency, Varicose vein, Crenobalneotherapy, Balneotherapy, Spa therapy

Brief summary

At 3 months, crenobalneotherapy session is superior to waiting list for patients with chronic venous insufficiency.

Interventions

BEHAVIORALCrenobalneotherapy

18 days of balneotherapy session in 3 weeks. Each day, the treatment associates 4 techniques: Kneipp Therapy, walking pool, underwater massage, bath tub and finishing with 20 minutes of rest in the Trendelendburg position. Kneipp Therapy is an alternating warm (28°C) and cold (14°C) shower on the legs during 10 minutes. Walking pool is a 60 cm deep pool at 23°C with underwater shower where patients are walking without stopping during 10 minutes. Underwater massage is realized by a senior physiotherapist. It starts at the feet and gradually rises to the thighs during 10 minutes. Bath tub is underwater shower at 30°C. It also starts at the feet and gradually rises to the thighs during 20 minutes. The interventions are standardized by timers. Adherence to each technique is supervised before each session in the usual manner for each patient treated in the spa center.

Sponsors

Centre de Recherche Rhumatologique et Thermal
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* patients aged 18 to 80 years with chronic venous insufficiency regardless of etiology stages 3 or 4 according to the CEAP classification (Clinical severity, Etiology or cause, Anatomy, Pathophysiology) * Patients available to participate in a 3 weeks session in the spa center and to be followed for 6 months

Exclusion criteria

* pregnant women, * contra-indication for the spa treatment (chronic infectious diseases, cancer, heart failure, serious liver or kidney disease, open leg ulcer, psychiatric disorders, immune deficiency, phlebitis, erysipelas or history of erysipelas); * surgery in the next three months, * spa treatment in the previous 6 months, * professional involvement with a spa resort

Design outcomes

Primary

MeasureTime frameDescription
number of patient with 20% improvement of CIVIC scale at 3 months3 monthsPrimary outcome is the number of patient with 20% improvement in quality of life (CIVIC scale) at 3 months

Secondary

MeasureTime frameDescription
associated treatment1 & 3 monthsDrug consumption is estimated on the last 3 days prior to the evaluation. Surgery, hospitalization for venous insufficiency and adherence to compression therapy
CIVIC1 monthChronic Venous Insufficiency Questionnaire (CIVIQ 2) 20% improvement. disease-specific QOL score for patients with chronic venous disease. The total score is derived from 20 questions (items) that represent four QOL dimensions (of 3-9 items each): bodily pain, physical, social and psychological functioning. The possible scores for each item are as follows: 1, negative; 2, weak; 3, moderate; 4, strong; 5, severe. The total scores can therefore vary from 20 (no symptoms) to 100 (worse possible condition).
civic1 & 3 monthsevolution of civic scale
opinion of patient and practitionner1 & 3 monthsOpinion of patient and practitioner is determined on a 5 point Lickert scale (very aggravated, aggravated, unchanged, improved and very improved)
PASS1 & 3 monthsPASS is measured by asking the patient if he/she feels he/she is in an acceptable clinical condition in terms of its venous insufficiency. We measure the number of patients with PASS
side effectsweek 1 & 3. 1 & 3 monthsside effects are collected by therapists and assessor. we collected the number of patients with side effects and the type of side effect
Rutherford severity score1 & 3 monthsclinical evaluation of severity taking into account 10 attributes: pain, varicose veins, venous edema, skin pigmentation, and adherence to compressive therapy, inflammation, induration, number, size and duration of active ulcer. Each attribute is scored 0 (minimum) to 2 (maximum).

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026